“Neonatal Hyperbilirubinemia: Etiology, Symptoms and Management”
Event Navigation
Philips Healthcare presents…a program in the Better Outcomes webinar series
“Neonatal Hyperbilirubinemia: Etiology, Symptoms and Management”
Neonatal hyperbilirubinemia is benign in healthy infants, but can be a significant clinical condition in high-risk babies. An understanding of the pathophysiology, etiologies and management is essential for the nurse when caring for neonates. This CE activity will discuss the physiology, pathophysiology, etiologies, clinical signs and symptoms and therapeutic management of neonates with conjugated/unconjugated bilirubin.
After review of the module, the participant will be able to:
- Discuss the physiology and pathophysiology of hyperbilirubinemia
- Identify etiologies of neonatal hyperbilirubinemia
- Evaluate treatment strategies, including phototherapy, for the neonate with hyperbilirubinemia
Presenter:
Terese Verklan, RN, CCNS, PhD, FAAN, Professor at the University of Texas Medical Branch School of Nursing in Galveston, TX
There is no cost for this program.
Target audience: Nurses
Continuing Education Credit:
- Nurses: This education activity is approved for 1.0 contact hour. Provider approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.
Please register to watch the webinar. Once you have completed viewing the webinar, you will able to log onto www.saxetesting.com/bo and complete the evaluation and post-test to receive your CE certificate of completion.
NOTE: It will appear you are registering for the live program on Feb. 22. Once you register you will obtain access to these two CE accredited on-demand webinars:
Neonatal Hyperbilirubinemia: A Clinical Overview
Positioning for Comfort and Growth
